After approval by the FDA, AVT03 is expected to be supplied in a single-dose prefilled syringe containing 60 mg in a 1 ml solution, as well as a 120 mg/1.7 ml solution in a single-dose vial.

See inside the L.E. Phillips-Libertas Treatment Center which closed suddenly in 2024 and find out what’s in store for a new ...

Pure Source, a U.S.-owned and operated contract manufacturer and global supplier of personal care and OTC products, proudly ...

Alembic Pharmaceuticals stated that the United States Food and Drug Administration (US FDA) had conducted an inspection at the company's bioequivalence facility located at Vadodara from 3rd to 7th of ...

DexCom DXCM-2.10%decrease; red down pointing triangle received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz. facilities and is ...

(Reuters) -Medical device maker Dexcom (NASDAQ:DXCM) said it has received a warning letter from the U.S. Food and Drug Administration following inspections of its two key manufacturing facilities ...

(Reuters) -Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following inspections of its two key manufacturing facilities, sending its ...

Elite, a specialty pharmaceutical company developing niche generic products, has shipped its first lot of finished product from its new FDA-approved expanded campus. The new facility, in Northvale ...

Marty Makary, likely FDA commissioner under President Trump, appeared before Congress this week as the agency he’s set to lead continues to be rocked by sweeping changes and about-faces. The sweeping ...